157 related articles for article (PubMed ID: 898899)
61. Combined protective effect of an immunostimulatory bacterial preparation and rimantadine in experimental influenza A virus infection.
Serkedjieva J; Ivanova E
Acta Virol; 1997 Apr; 41(2):65-70. PubMed ID: 9219635
[TBL] [Abstract][Full Text] [Related]
62. [The protective effect of polyI-C and rimantadine in experimental infections caused by Bimiti arbovirus].
Fadeeva LL; Lomonosov NN
Antibiotiki; 1974 Mar; 19(3):240-3. PubMed ID: 4463861
[No Abstract] [Full Text] [Related]
63. The influence of the antiviral drugs amantadine and rimantadine on erythrocyte and platelet membranes and its comparison with that of tetracaine.
Donath E; Herrmann A; Coakley WT; Groth T; Egger M; Taeger M
Biochem Pharmacol; 1987 Feb; 36(4):481-7. PubMed ID: 3030325
[TBL] [Abstract][Full Text] [Related]
64. [Influenza virus replication in the presence of bonafton and other inhibitors of macromolecular synthesis].
Farashian VR; Gerasina SF; Poliakova IA; Fadeeva NI; Zhdanov VM
Vopr Virusol; 1985; 30(2):174-80. PubMed ID: 4002692
[TBL] [Abstract][Full Text] [Related]
65. Virion transcriptase activity of rimantadine-sensitive and rimantadine-resistant variants of human influenza virus.
Indulen MK; Kalninya VA; Gorodkova NV; Akopova II; Ghendon YuZ
Acta Virol; 1987 Nov; 31(6):458-62. PubMed ID: 2894138
[TBL] [Abstract][Full Text] [Related]
66. [Change in the sensitivity of influenza virus, replicating in the presence of rimantadine, to antiviral agents].
Boreko EI; Pavlova NI; Votiakov VI
Vopr Virusol; 1999; 44(3):115-9. PubMed ID: 10392434
[TBL] [Abstract][Full Text] [Related]
67. [The anti-influenza effect of rimantadine and isoprinosine when used in combination in mice].
Pancheva S; Gegova G; Maksimova V; Manolova N
Acta Microbiol Bulg; 1990; 26():26-9. PubMed ID: 1711269
[TBL] [Abstract][Full Text] [Related]
68. [Effect of sodium selenite and its combination with remantadine on the synthesis of virus-specific polypeptides in a cell culture infected with influenza A virus].
Abdullaev II; Asadullaev TB; Abdullaev FI
Vopr Virusol; 1988; 33(6):676-80. PubMed ID: 3247686
[TBL] [Abstract][Full Text] [Related]
69. Combination of peramivir and rimantadine demonstrate synergistic antiviral effects in sub-lethal influenza A (H3N2) virus mouse model.
Bantia S; Kellogg D; Parker CD; Babu YS
Antiviral Res; 2010 Dec; 88(3):276-80. PubMed ID: 20943201
[TBL] [Abstract][Full Text] [Related]
70. Adamantylthiourea derivatives as antiviral agents.
Tilley JW; Levitan P; Kramer MJ
J Med Chem; 1979 Aug; 22(8):1009-10. PubMed ID: 490532
[TBL] [Abstract][Full Text] [Related]
71. [Prevention of the formation of a mutant influenza A virus resistant to rimantadine (alpha-methyl-1-adamantanemethylamine hydrochloride) by using ribavirin (1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide)].
Pushkarskaia NL; L'vov ND; Galegov GA
Vopr Virusol; 1980; (3):303-6. PubMed ID: 7434722
[TBL] [Abstract][Full Text] [Related]
72. [Tissue reaction and influenza virus infectiousness during multiplication in tissue culture in the presence of remantadine].
Votiakov VI; Boreko EI; Zaporozhets LK
Vopr Virusol; 1984; 29(4):468-73. PubMed ID: 6495707
[TBL] [Abstract][Full Text] [Related]
73. In vitro antiviral activity and preliminary clinical trials of a new adamantane compound.
Mathur A; Beare AS; Reed SE
Antimicrob Agents Chemother; 1973 Oct; 4(4):421-6. PubMed ID: 4364762
[TBL] [Abstract][Full Text] [Related]
74. Rimantadine therapy of influenza A infection in mice.
Rabinovich S
Antimicrob Agents Chemother; 1972 May; 1(5):408-11. PubMed ID: 4670482
[TBL] [Abstract][Full Text] [Related]
75. Alteration in the antigenic structure of M1 protein of influenza A virus mutant resistant to a new antiviral compound mopyridone.
Galabov AS; Khristova ML; Uzunov S; Wassilewa L; Bucher DJ; Kharitonenkov IG
Acta Virol; 1994 Feb; 38(1):5-10. PubMed ID: 7520664
[TBL] [Abstract][Full Text] [Related]
76. Treatment of influenza infection of mice by using rimantadine hydrochlorides by the aerosol and intraperitoneal routes.
Stephen EL; Dominik JW; Moe JB; Spertzel RO; Walker JS
Antimicrob Agents Chemother; 1975 Aug; 8(2):154-8. PubMed ID: 1180541
[TBL] [Abstract][Full Text] [Related]
77. [Effect of alpha-methyl-L-adamantane methylamine hydrochloride (remantadine) on polypeptide formation in an influenza virus A-infected cell culture].
Iatsyna AA
Vopr Virusol; 1979; (1):84-5. PubMed ID: 419744
[No Abstract] [Full Text] [Related]
78. Influence of membrane (M) protein on influenza A virus virion transcriptase activity in vitro and its susceptibility to rimantadine.
Zvonarjev AY; Ghendon YZ
J Virol; 1980 Feb; 33(2):583-6. PubMed ID: 6893343
[TBL] [Abstract][Full Text] [Related]
79. Synthesis and antiviral activities of adamantane spiro compounds. 1. Adamantane and analogous spiro-3'-pyrrolidines.
Lundahl K; Schut J; Schlatmann JL; Paerels GB; Peters A
J Med Chem; 1972 Feb; 15(2):129-32. PubMed ID: 4332673
[No Abstract] [Full Text] [Related]
80. Synthesis and antiviral activities of adamantane spiro compounds. 2.
Smit A; Kralt T; Peters A; van Hes R
J Med Chem; 1972 Feb; 15(2):132-6. PubMed ID: 5008237
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
